Taiwan's HCmed Innovations Co., a contract development and manufacturing organisation (CDMO), ahas nnounced the appointment of Gunilla Petersson, Ph.D. as the new Chief Scientific Officer (CSO). In her role as CSO, Dr Gunilla will contribute to the company's strategic business development, while providing professional advice with regards to combination product development.    

Former Science and Innovation Director of Inhaled Drug Delivery at AstraZeneca, Dr Gunilla joins HCmed with more than 29 years of experience in the pharmaceutical industry. Affiliated to the Innovation Strategies & Internal Liaison segment, in most recent years, she dedicated herself to novel technology scouting, due diligence activities, and scientific marketing.

During her extended and successful professional career, she has accumulated a vast number of connections with global pharmaceutical companies and renowned experts in the field.